OBIO Competitors & Alternatives
Compare Orchestra BioMed Holdings Inc. with similar stocks in the same industry
Biotechnology
OBIO
Main Stock$3.93
Tradestie Score
52
Market Cap
$137.59M
Revenue Growth
121.2%
Analyst Upside
+216.2%
Top Competitors
236 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DBVT
DBV Technologies S.A.
|
$19.99
|
$275.54M | - | 49 | Compare |
|
ALLO
Allogene Therapeutics, Inc. Common Stock
|
$2.27
|
$275.13M | - | 47 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$16.08
|
$269.08M | - | 54 | Compare |
|
ZURA
Zura Bio Limited Class A Ordinary Shares
|
$4.54
|
$262.67M | - | 51 | Compare |
|
KYTX
Kyverna Therapeutics, Inc. Common Stock
|
$9.30
|
$258.18M | - | 51 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 53 | Compare |
|
NGNE
Neurogene, Inc. Common Stock
|
$31.26
|
$256.54M | - | 70 | Compare |
|
OABI
OmniAb, Inc. Common Stock
|
$1.47
|
$231.77M | - | 55 | Compare |
|
SGMT
Sagimet Biosciences Inc. Series A Common Stock
|
$7.64
|
$227.00M | - | 56 | Compare |
|
TRDA
Entrada Therapeutics, Inc. Common Stock
|
$6.85
|
$223.66M | - | 49 | Compare |
More OBIO Analysis
Data updated: May 08, 2026 | Industry: Biotechnology (SIC 3841)
236 stocks in this industry